Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
175,611,455
-
Total 13F shares
-
75,500,303
-
Share change
-
+4,074,423
-
Total reported value
-
$16,542,105,508
-
Put/Call ratio
-
120%
-
Price per share
-
$219.24
-
Number of holders
-
722
-
Value change
-
+$917,730,488
-
Number of buys
-
439
-
Number of sells
-
270
Institutional Holders of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) as of Q3 2020
As of 30 Sep 2020,
Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) was held by
722 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
75,500,303 shares.
The largest 10 holders included
VANGUARD GROUP INC, BAILLIE GIFFORD & CO, BlackRock Inc., JENNISON ASSOCIATES LLC, Capital World Investors, BANK OF AMERICA CORP /DE/, ARK Investment Management LLC, JPMORGAN CHASE & CO, STATE STREET CORP, and Discovery Value Fund.
This page lists
728
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.